Advertisement

Genetic Control and Immunity

  • Edna Mozes
  • G. M. Shearer
  • Michael Sela
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 31)

Abstract

For more than half a century a correlation has been known to exist between the ability to respond to an antigen and the genetic constitution of an individual. In 1916, Cooke and van der Veer provided experimental evidence that inheritance plays a role in some forms of human sensitization, e.g., hay fever, bronchial asthma, gastro-enteritis and urticaria (1). Furthermore, these investigators concluded that this phenomenon is inherited as a dominant characteristic, involving the ability of an individual to form specific antibodies, and is not due to transmission of sensitization from parent to offspring. Thus, the ability of an individual to elicit an immune response to a given immunogen is genetically affected, although the immune state of that individual is not itself an inherited characteristic. Recent analyses of animal and human disease states suggest that genes which control immune responsiveness affect susceptibility or resistance to certain diseases (2). In order to understand these phenomena in humans, experimental models using inbred mice (in which the genetic parameters can be controlled) and synthetic polypeptide antigens (in which the chemical structure can be defined) have been studied.

Keywords

Genetic Control Spleen Cell High Responder Positive Seron Thymus Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cooke, R.A. & Vander Veer, A. J. Immunol. 1:201, 1916.Google Scholar
  2. 2.
    McDevitt, H.O. & Bodmer, W.F. Am. J. Med. 52:1, 1972.PubMedCrossRefGoogle Scholar
  3. 3.
    McDevitt, H.O. & Sela, M. J. Exper. Med. 122:317, 1965.CrossRefGoogle Scholar
  4. 4.
    McDevitt, H.O. & Sela, M. J. Exper. Med. 126:969, 1967.CrossRefGoogle Scholar
  5. 5.
    Mozes, E., McDevitt, H.O., Jaton, J-C. & Sela, M. J. Exper. Med. 130:493, 1969.CrossRefGoogle Scholar
  6. 6.
    Mozes, E., McDevitt, H.O., Jaton, J-C. & Sela, M. J. Exp. Med. 130:1263, 1969.PubMedCrossRefGoogle Scholar
  7. 7.
    MOZES, E., MARON, E., ARNON, R. & SELA, M. J. Immunol. 106: 862, 1971.PubMedGoogle Scholar
  8. 8.
    Shearer, G.M., Cudkowicz, G., & Priore, R.L. J. Exper. Med. 129:185, 1969.CrossRefGoogle Scholar
  9. 9.
    Shearer, G.M. & Cudkowicz, G. J. Exper. Med. 129:933, 1969.Google Scholar
  10. 10.
    Nossal, G.J.V., Cunningham, A., Mitchell, G.F. & Miller, J.F. A.P. J. Exper. Med. 128:839, 1968.CrossRefGoogle Scholar
  11. 11.
    Mitchison, N.A. Eur. J. Immunol. 1:18, 1971.PubMedCrossRefGoogle Scholar
  12. 12.
    Mozes, E., Shearer, G.M. & Sela, M. J. Exper. Med. 132:613, 1970.CrossRefGoogle Scholar
  13. 13.
    Shearer, G.M., Mozes, E. & Sela, M. J. Exper. Med. 133:216, 1971.CrossRefGoogle Scholar
  14. 14.
    Mozes, E. & Shearer, G.M. J. Exper. Med. 134:141, 1971.CrossRefGoogle Scholar
  15. 15.
    Shearer, G.M., Mozes, E. & SELA, M. J. Exper. Med. 135: 1972 (in press).Google Scholar
  16. 16.
    Braun, W. & Nakano, M. Science 157:819, 1967.PubMedCrossRefGoogle Scholar
  17. 17.
    Winchurch, R. & Braun, W. Nature 223:843, 1969.PubMedCrossRefGoogle Scholar
  18. 18.
    Mozes, E., Shearer, G.M., Sela, M. & Braun, W. Conversion with polynucleotides of a genetically controlled low immune response to a high response in mice immunized with a synthetic polypeptide antigen. In: Biological Effects of Polynucleotides, p. 162, R.F. Beers and W. Braun, Eds., Springer-Verlag, New York, 1970.Google Scholar
  19. 19.
    Green, I., Paul, W.E. & Benacerraf, B. J. Exper. Med. 123: 859, 1966.CrossRefGoogle Scholar
  20. 20.
    McDevitt, H.O. J. Immunol. 100:483, 1968.Google Scholar

Copyright information

© Plenum Press, New York 1972

Authors and Affiliations

  • Edna Mozes
    • 1
  • G. M. Shearer
    • 1
  • Michael Sela
    • 1
  1. 1.Department of Chemical ImmunologyThe Weizmann Institute of ScienceRehovothIsrael

Personalised recommendations